Evidence that Aβ fibril polymorphism may correlate with variations in clinical and pathological features of AD includes: (i) Aβ40 fibrils with different molecular structures exhibit different levels of toxicity in primary neuronal cell cultures^[@R1]^; (ii) Patterns of amyloid deposition in transgenic mice, induced by exogenous amyloid-containing biological material, vary with the source of this material^[@R13],[@R14]^; (iii) The size and composition of amyloid plaques induced in transgenic mice by synthetic Aβ42 fibrils depend on the morphology and growth conditions of these fibrils^[@R15]^; (iv) Size distributions and resistance to chemical denaturation of Aβ42 aggregates in brain tissue differ in rapidly progressing and slowly progressing AD patients.^[@R16]^ Improved characterization of the structures of neurotoxic Aβ assemblies in AD and of correlations between structure and disease phenotype would have a major impact on our understanding of pathogenesis, on the development of appropriate diagnostic and therapeutic biomarkers, and on drug development.

Data from ssNMR are particularly sensitive to structural variations, allowing two-dimensional (2D) ^13^C-^13^C and ^15^N-^13^C ssNMR spectra to be used as "fingerprints" of specific fibril polymorphs.^[@R1],[@R4],[@R20],[@R21]^ Since ssNMR requires milligram-scale quantities of isotopically labeled fibrils, we amplified and labeled structures in brain tissue by seeded growth, using brain tissue as the source of fibril seeds, as described by Lu *et al*.^[@R4]^

By analogy with prion diseases, in which different strains produce different durations of illness, preferentially target different brain regions, and are associated with conformational differences in disease-related prion proteins^[@R17]--[@R19],[@R22]^, we selected tissue samples from patients from two unusual AD subtypes, namely PCA-AD, which is associated with disruption of visual processing^[@R23]^, and r-AD, in which neurodegeneration occurs within months and which clinically resembles Creutzfeldt-Jakob disease.^[@R24]^ We also included tissue from three individuals who died without dementia (ND) but who were found to have Aβ deposition at autopsy.

We separately prepared Aβ40 and Aβ42 fibrils by seeded growth from amyloid-enriched cortical extracts. Transmission electron microscope (TEM) images were acquired for all fibril samples. ssNMR measurements were attempted for all samples, although in some cases the signal-to-noise ratios were insufficient for acquisition or subsequent analysis of 2D spectra. [Table 1](#T1){ref-type="table"} summarizes the tissue samples, patient categories, and ssNMR measurements. Examples of TEM images and full sets of 2D spectra are given in [Extended Data Figs. 1](#F5){ref-type="fig"}--[3](#F7){ref-type="fig"}. Control experiments with cortical extract from a non-AD patient who did not have significant Aβ deposition are described in the [Supplementary Discussion](#SD1){ref-type="supplementary-material"} and [Extended Data Fig. 4](#F8){ref-type="fig"}.

[Fig. 1](#F1){ref-type="fig"} shows representative data for Aβ40 fibrils. In TEM images ([Fig. 1a](#F1){ref-type="fig"} and [Extended Data Fig. 1](#F5){ref-type="fig"}), certain fibrils exhibit modulations of their apparent width with a period of 107 ± 20 nm (mean and standard deviation based on 65 measurements). This fibril morphology may be more abundant in images of Aβ40 fibrils derived from t-AD and PCA-AD tissue samples. However, quantification of the relative populations of fibril polymorphs from the TEM images is not possible because only a small subset of the fibrils can be visualized clearly. In contrast, all fibrils contribute to the 2D ssNMR spectra. Most 2D spectra of brain-seeded Aβ40 fibrils contain the same set of strong crosspeak signals, indicated by assignments to the isotopically labeled residues in [Figs. 1b and 1c](#F1){ref-type="fig"}, while spectra of certain samples contain additional crosspeak signals with varying intensities.

[Fig. 2](#F2){ref-type="fig"} shows representative data for Aβ42 fibrils. TEM images do not show a single morphology that is clearly predominant within any of the tissue categories ([Fig. 2a](#F2){ref-type="fig"}). 2D spectra of most samples do not show a single set of crosspeak signals from the isotopically labeled residues ([Figs 2b and 2c](#F2){ref-type="fig"}).

We analyzed the 2D ssNMR spectra with two independent methods, both intended to be objective and devoid of assumptions regarding the nature of the fibril structures or structural variations. Only 2D spectra with adequate signal-to-noise ratios (see [Supplementary Methods](#SD2){ref-type="supplementary-material"}) were included in these analyses. In the first method, we compared each 2D spectrum in a given set (^13^C-^13^C or ^15^N-^13^C, Aβ40 or Aβ42) with all other 2D spectra in the same set. Comparisons were quantified by pairwise root-mean-squared deviation (RMSD) values between 2D spectra, calculated as described in the [Supplementary Methods](#SD1){ref-type="supplementary-material"}. For 2D ^13^C-^13^C and ^15^N-^13^C spectra of Aβ40 fibrils, plots in [Fig. 3](#F3){ref-type="fig"} indicate that RMSDs among spectra from t-AD and PCA-AD samples are relatively small (blue shades) in most cases, while RMSDs between spectra from r-AD samples and spectra from either t-AD or PCA-AD samples are relatively large (red shades). Thus, t-AD and PCA-AD spectra are similar to one other, but contrast sharply with r-AD spectra, which have larger variability.

Statistics are summarized in [Extended Data Table 1a](#T2){ref-type="table"}. Mean RMSDs among t-AD spectra are not significantly different from mean RMSDs between t-AD spectra and PCA-AD spectra. However, mean RMSDs among t-AD spectra or among PCA-AD spectra are significantly smaller than mean RMSDs between t-AD spectra and r-AD spectra or between PCA-AD spectra and r-AD spectra (p \< 0.001, Welch's t-test). In addition, for 2D ^15^N-^13^C spectra of Aβ40 fibrils, the mean RMSD value among PCA-AD spectra is significantly smaller than the mean RMSD value among t-AD spectra, the mean RMSD value among PCA-AD spectra is significantly smaller than the mean RMSD value among r-AD spectra, and the mean RMSD value among tAD spectra is significantly smaller than the mean RMSD value among r-AD spectra (p \< 0.001).

For 2D spectra of Aβ42 fibrils, plots in [Fig. 3](#F3){ref-type="fig"} do not show clear patterns, and no statistically significant differences among mean RMSDs are identified.

In the second method of analysis, we used singular value decomposition to determine principal component spectra^[@R25]^ for each set of 2D spectra (see [Supplementary Methods](#SD1){ref-type="supplementary-material"}). For each set, the number N of principal component spectra equals the number of experimental 2D spectra. The experimental spectra within each set, including both crosspeak signals and random noise, can be represented exactly as linear combinations of the principal component spectra ([Extended Data Figs. 5](#F9){ref-type="fig"} and [6](#F10){ref-type="fig"}), with coefficients C~k~ (k = 1, 2,..., N). As shown in [Fig. 4](#F4){ref-type="fig"} and [Extended Data Table 1b](#T2){ref-type="table"}, mean values of C~2~ for ^13^C-^13^C and ^15^N-^13^C spectra of Aβ40 fibrils derived from r-AD tissue are significantly larger than the corresponding mean values of C~2~ for both t-AD spectra and PCA-AD spectra (p \< 0.01). This indicates that 2D spectra of Aβ40 fibrils derived from r-AD tissue differ more strongly from the average 2D spectra than do spectra of Aβ40 fibrils derived from t-AD and PCA-AD tissue. For Aβ42 fibrils, differences in mean values of C~k~ are not significant.

An alternative analysis of the 2D ^15^N-^13^C spectra, in which the spectra were fit with a fixed number of crosspeaks at fixed chemical shift positions, is described in the [Supplementary Methods](#SD1){ref-type="supplementary-material"} and [Extended Data Fig. 7](#F11){ref-type="fig"}. According to this analysis, on average, the predominant Aβ40 fibril structure typically accounts for approximately 80% of the crosspeak signal volume in 2D ^15^N-^13^C spectra of Aβ40 fibrils derived from t-AD and PCA-AD tissue, and approximately 65% in 2D ^15^N-^13^C spectra of Aβ40 fibrils derived from r-AD tissue. ^15^N and ^13^C chemical shifts in our spectra of brain-seeded fibrils are compared with previously reported chemical shifts for Aβ40 and Aβ42 fibrils^[@R1],[@R2],[@R4],[@R6],[@R7],[@R26]--[@R28]^ in the [Supplementary Discussion](#SD1){ref-type="supplementary-material"} and [Extended Data Fig. 8](#F12){ref-type="fig"}.

We draw the following main conclusions from these ssNMR experiments: (i) Although brain-seeded Aβ40 fibrils can be polymorphic, a single structure is most abundant in cortical tissue of most t-AD patients and most PCA-AD patients; (ii) Polymorphism of Aβ40 fibrils is more pronounced in r-AD samples than in t-AD and PCA-AD samples; (iii) Brain-seeded Aβ42 fibrils are generally more structurally heterogeneous than brain-seeded Aβ40 fibrils, without a clearly predominant structure even in t-AD and PCA-AD samples. Although the small number of samples prevents us from drawing definite conclusions regarding fibril structures in ND brain tissue, we have not observed ssNMR signals that are unique to ND-derived fibrils.

2D ssNMR spectra of the predominant Aβ40 fibril structure, along with the fibril morphology in [Fig. 1a](#F1){ref-type="fig"}, match data reported previously by Lu *et al.* for Aβ40 fibrils from one of their two AD patients.^[@R4]^ This patient, called "patient 2", was a t-AD case. In contrast, Aβ40 fibrils from their "patient 1" exhibited distinctive ssNMR signals that are not present in any of the measurements described above ([Extended Data Fig. 8](#F12){ref-type="fig"}). The clinical history of patient 1 was also different, including an initial diagnosis of Lewy body dementia rather than AD. Thus, it remains possible that the Aβ40 fibril structure of patient 1, for which a full molecular model was developed^[@R4]^, is associated with a specific AD variant.

The indistinguishability of Aβ fibrils from t-AD and PCA-AD tissue suggests that phenotypic differences between these two categories arise from factors other than fibril structure, perhaps including genetic factors or differences in nonfibrillar Aβ assemblies. The greater polymorphism of Aβ40 fibrils from r-AD tissue indicated by 2D ssNMR spectra has at least two possible interpretations: (i) A fibril structure that is prevalent in r-AD tissue has enhanced neurotoxicity, through either direct or indirect mechanisms; (ii) In r-AD samples, fibrils reside in the tissue for a shorter period than in t-AD and PCA-AD samples, possibly allowing fibrils with a greater range of thermodynamic stabilities or resistance to degradation to be present at autopsy.

The greater overall heterogeneity of Aβ42 fibrils seeded with t-AD and PCA-AD extract, compared with the corresponding Aβ40 fibrils, is conceivably a consequence of imperfect amplification of Aβ42 fibril structures from brain tissue under our experimental conditions, possibly due to a stronger tendency of the more hydrophobic Aβ42 peptide to spontaneously form nonfibrillar aggregates or due to the lower abundance of Aβ42 fibrils in most of our tissue samples ([Extended Data Table 2](#T3){ref-type="table"}). However, 2D ssNMR spectra of a control sample, in which Aβ42 fibrils were grown in the presence of extract from occipital tissue that lacked detectable fibril seeds, show surprisingly sharp crosspeak signals that indicate roughly 70% population of a single structure ([Supplementary Discussion](#SD1){ref-type="supplementary-material"} and [Extended Data Fig. 4](#F8){ref-type="fig"}). Thus, the greater structural heterogeneity of AD brain-seeded Aβ42 fibrils in our experiments most likely indicates greater heterogeneity of the fibril seeds within the cortical tissue. Recent experiments by Cohen *et al*. indicate differences in structural heterogeneity and sizes of Aβ42 aggregates, but not Aβ40 aggregates, in r-AD and t-AD brain tissue.^[@R16]^

In conclusion, experiments described above represent the first use of ssNMR to screen multiple tissue samples for variations in amyloid fibril structure. Similar approaches can be applied in other amyloid diseases, where related phenomena exist.^[@R20],[@R29],[@R30]^ Obvious goals for future work are to develop a full structural model for the predominant Aβ40 polymorph identified above and to determine whether structurally distinct Aβ40 polymorphs can consistently seed different patterns of Aβ pathology in suitable animal models.
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![Additional TEM images of brain-seeded fibrils\
(**a**) TEM grids were prepared 4 h after addition of solubilized Aβ40 or Aβ42 to sonicated brain extract and were negatively stained with uranyl acetate. Collagen fibrils in the extract (40--100 nm width, with characteristic transverse bands) appear in some images. Material with an amorphous appearance is nonfibrillar, non-Aβ components of the brain extract. Yellow arrows indicate Aβ40 fibrils with an apparent width modulation, attributable to an approximately periodic twisting of the fibril structure about the fibril growth direction. TEM images of all 37 brain-seeded Aβ40 and all 33 Aβ42 fibril samples are available on-line at <http://dx.doi.org/10.17632/whgp9r7tkd.1>. (**b**) Histogram of distances between width minima for Aβ40 fibrils with apparent width modulation. The Gaussian fit to this histogram (red curve) has a mean value of 107.2 nm (n = 65) and a full-width-at-half-maximum of 46.1 nm.](nihms832197f5){#F5}

![2D ssNMR spectra of brain-seeded Aβ40 fibrils\
**a,** 2D ^13^C-^13^C spectra of fibrils seeded with extract from t-AD, PCA-AD, r-AD, or ND tissue. Aliphatic regions are shown, with 15 contour levels increasing by successive factors of 1.3, and with the highest contour at the maximum signal in each 2D spectrum. **b,** 2D ^15^N-^13^C spectra of fibrils seeded with extract from t-AD, PCA-AD, r-AD, or ND tissue. Regions containing intra-residue ^15^N-^13^C~α~ crosspeaks are shown, with 11 contour levels increasing by successive factors of 1.3, and with the highest contour at the maximum signal in each spectrum. ^15^N-^13^C~β~ crosspeaks from L34 appear in some spectra. Positions of crosspeaks from the predominant Aβ40 fibril structure are indicated by color-coded circles (F19 = blue, V24 = cyan, G25 = pink, S26 = orange, A30 = purple, I31 = red, L34 = green, M35 = magenta). Only 2D spectra that were included in the analyses in [Figs. 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"} of the main text are shown. The full set of 42 2D ^13^C-^13^C spectra and 40 2D ^15^N-^13^C spectra, including those with lower signal-to-noise, controls, and technical replicates, is available on-line at <http://dx.doi.org/10.17632/tbp45pm92x.1>.](nihms832197f6){#F6}

![2D ssNMR spectra of brain-seeded Aβ42 fibrils\
**a,** 2D ^13^C-^13^C spectra of fibrils seeded with extract from t-AD, PCA-AD, r-AD, or ND tissue. Aliphatic regions are shown, with 15 contour levels increasing by successive factors of 1.3, and with the highest contour at the maximum signal in each spectrum. **b,** 2D ^15^N-^13^C spectra of fibrils seeded with extract from t-AD, PCA-AD, r-AD, or ND tissue. Regions containing intra-residue ^15^N-^13^C~α~ crosspeaks are shown, with 11 contour levels increasing by successive factors of 1.3, and with the highest contour at the maximum signal in each spectrum. Only 2D spectra that were included in the analyses in [Figs. 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"} of the main text are shown. The full set of 33 2D ^13^C-^13^C spectra and 23 2D ^15^N-^13^C spectra, including those with lower signal-to-noise, controls, and technical replicates, is available on-line at <http://dx.doi.org/10.17632/tbp45pm92x.1>.](nihms832197f7){#F7}

![Control experiments using cortical tissue without Aβ deposits\
Occipital tissue of a female who died from cardiac arrest at age 86 was used as a control. **a,** Comparison of TEM images of control tissue extract and r-AD2p′ extract after incubation for 4.0 h with solubilized Aβ40, under conditions identical to those that led to fibrils shown in [Extended Data Fig. 1a](#F5){ref-type="fig"}. Fibrils associated with brain material were abundant on the TEM grid of the r-AD2p′-seeded sample, but were not observed in an extensive search over the TEM grid of the control sample. **b,** TEM images of control tissue extract and r-AD2p′ extract after incubation for 4.0 h with solubilized Aβ42, under conditions identical to those that led to fibrils shown in [Extended Data Fig. 1b](#F5){ref-type="fig"}. Fibrils associated with brain material were abundant on the TEM grid of the r-AD2p′-seeded sample, but were not observed in an extensive search over the TEM grid of the control sample. **c,** 2D ^13^C-^13^C and ^15^N-^13^C spectra of Aβ40 fibrils (blue) and Aβ42 fibrils (red) that developed in control samples after 168 h or 48 h incubation, respectively, followed by 24 h intermittent sonication (see [Supplemental Methods](#SD1){ref-type="supplementary-material"}), followed by 72 h additional incubation. Contour levels increase by successive factors of 1.4. **d,** RMSDs between 2D spectra of control fibrils and 2D spectra of AD brain-seeded fibrils, with dashed lines at RMSD values corresponding to white shades in [Fig. 3](#F3){ref-type="fig"} of the main text.](nihms832197f8){#F8}

![Principal component analyses of 2D ^13^C-^13^C and ^15^N-^13^C ssNMR spectra of brain-seeded Aβ40 fibrils\
**a**, The first five principal components (PC1-PC5) of the 32 experimental 2D ^13^C-^13^C spectra, shown as contour plots with positive contours in blue and negative contours in red. Principal component spectra were obtained by singular value decomposition of the experimental spectra, considering only the aliphatic region and excluding points within 5 ppm of the diagonal. Contour levels increase (or decrease, in the case of negative contours) by successive factors of 1.5. **b**, Experimental 2D ^13^C-^13^C spectrum of t-AD4f Aβ40 fibrils (left) and 2D spectrum constructed as a linear combination of PC1-PC5 (right, with coefficients of PC1-PC5 shown in parentheses). **c**, Experimental 2D ^13^C-^13^C spectrum of r-AD1f Aβ40 fibrils (left) and 2D spectrum constructed as a linear combination of PC1-PC5 (right). **c**, The first five principal components of the 29 experimental 2D ^15^N-^13^C spectra. **d**, Experimental 2D ^15^N-^13^C spectrum of PCA2p Aβ40 fibrils (left) and 2D spectrum constructed as a linear combination of PC1-PC5 (right). **e**, Experimental 2D ^15^N-^13^C spectrum of r-AD2o Aβ40 fibrils (left) and 2D spectrum constructed as a linear combination of PC1-PC5 (right).](nihms832197f9){#F9}

![Principal component analyses of 2D ^13^C-^13^C and ^15^N-^13^C ssNMR spectra of brain-seeded Aβ42 fibrils\
**a**, The first five principal components (PC1-PC5) of the 17 experimental 2D ^13^C-^13^C spectra, plotted as in [Extended Data Fig. 5](#F9){ref-type="fig"}. **b**, Experimental 2D ^13^C-^13^C spectrum of t-AD1p Aβ42 fibrils (left) and 2D spectrum constructed as a linear combination of PC1-PC5 (right, with coefficients of PC1-PC5 shown in parentheses). **c**, Experimental 2D ^13^C-^13^C spectrum of r-AD2f Aβ42 fibrils (left) and 2D spectrum constructed as a linear combination of PC1-PC5 (right). **c**, The first five principal components of the 15 experimental 2D ^15^N-^13^C spectra. **d**, Experimental 2D ^15^N-^13^C spectrum of t-AD3f Aβ42 fibrils (left) and 2D spectrum constructed as a linear combination of PC1-PC5 (right). **e**, Experimental 2D ^15^N-^13^C spectrum of r-AD2p Aβ42 fibrils (left) and 2D spectrum constructed as a linear combination of PC1-PC5 (right).](nihms832197f10){#F10}

![Analysis of 2D ^15^N-^13^C ssNMR spectra of brain-seeded fibrils by fitting with crosspeaks at fixed chemical shift positions\
**a,** Examples of 2D spectra (out of the 29 Aβ40 and 15 Aβ42 spectra with adequate signal-to-noise in [Table 1](#T1){ref-type="table"}), with fitted crosspeak positions indicated by crosses. Red and blue crosses indicate crosspeaks for chemical shift sets "a" and "b", respectively (see [Supplementary Methods](#SD1){ref-type="supplementary-material"}, [Supplementary Discussion](#SD1){ref-type="supplementary-material"}, and [Extended Data Fig. 8](#F12){ref-type="fig"}). Cyan crosses indicate additional crosspeaks. Contour levels increase by successive factors of 1.4. **b,** Pairwise differences among fitted crosspeak volumes for spectra of Aβ40 fibrils (left) and Aβ42 fibrils (right), with color scales representing RMSD values. Total crosspeak volumes in each spectrum were normalized before calculation of RMSD values. Results from this crosspeak-fitting analysis are similar to results in [Fig. 3](#F3){ref-type="fig"}, in which the same experimental data were analyzed by direct comparisons of signal amplitudes in 2D spectra without fitting the signals with crosspeaks at specific positions. **c,** Fractions of the total fitted crosspeak volumes at "a" and "b" chemical shifts, with mean values indicated by horizontal bars. For Aβ40, mean values of "a" volumes in spectra of t-AD (n = 12) or PCA-AD (n = 6) samples are significantly greater than the mean value (n = 10) in spectra of r-AD samples (p \< 0.02, Welch's t-test; p \< 0.02, Mann-Whitney-Wilcoxon test).](nihms832197f11){#F11}

![Comparisons of ssNMR chemical shifts of brain-seeded Aβ40 and Aβ42 fibrils with previously reported chemical shifts\
**a,** ^15^N and ^13^C chemical shifts (ppm) from spectra of brain-seeded samples in [Table 1](#T1){ref-type="table"} (grouped into sets "a", "b", etc., based on correlations of the corresponding signal amplitudes over multiple 2D spectra) are compared with chemical shifts from previous ssNMR studies of Aβ40 and Aβ42 fibrils, as deposited in the Biological Magnetic Resonance Bank with the indicated BMRB accession numbers. **b,** Chemical shift differences after adjustments of chemical shift referencing in each set to make the average ^13^C~α~ shifts and the average ^15^N shifts equal in all sets.](nihms832197f12){#F12}

###### Statistical significance of analyses in [Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}

**a,** From [Fig. 3](#F3){ref-type="fig"}, mean RMSD values for pairs of 2D spectra within a given tissue category are compared with mean RMSD values between tissue categories or within a different tissue category. The significance of differences in mean RMSD values is assessed by Welch's t-test (two-sided). **b,** From [Fig. 4](#F4){ref-type="fig"}, mean values of coefficients of the second principal component in 2D spectra (C~2~) from three tissue categories are compared. The significance of differences in mean C~2~ values is assessed by Welch's t-test (two-sided).

  a                                                                                                             
  -------------------- ------------------ ------------- ------------- ------------- ------------- ------------- -------------
  Aβ40 ^13^C-^13^C     mean RMSD values   0.246,0.255   0.246,0.308   0.248,0.317   0.246,0.248   0.246,0.299   0.248,0.299
  t-statistic          −0.758             −6.48         −4.70         −0.11         −2.94         −2.29         
  degrees of freedom   182                147           50            54            40            60            
  p-value              0.45               \<0.001       \<0.001       0.91          0.005         0.026         
                                                                                                                
  Aβ40 ^15^N-^13^C     mean RMSD values   0.299,0.262   0.298,0.399   0.220,0.381   0.299,0.220   0.299,0.396   0.220,0.396
  t-statistic          2.17               −5.83         −8.15         4.77          −4.54         −8.50         
  degrees of freedom   134                165           67            53            84            57            
  p-value              0.032              \<0.001       \<0.001       \<0.001       \<0.001       \<0.001       
                                                                                                                
  Aβ42 ^13^C-^13^C     mean RMSD values   0.428,0.465   0.428,0.464   0.404,0.431   0.428,0.404   0.428,0.552   0.404,0.552
  t-statistic          −0.719             −0.55         −0.58         0.46          −0.56         −0.68         
  degrees of freedom   37                 39            38            35            2             2             
  p-value              0.48               0.59          0.56          0.65          0.63          0.57          
                                                                                                                
  Aβ42 ^15^N-^13^C     mean RMSD values   0.317,0.381   0.317,0.380   0.387,0.373   0.317,0.387   0.317,0.437   0.387,0.437
  t-statistic          −1.61              −1.31         0.191         −1.14         −0.804        −0.320        
  degrees of freedom   46                 36            12            8             2             3             
  p-value              0.11               0.20          0.85          0.29          0.012         0.77          

  b                                                                    
  -------------------- ------------------ ------------- -------------- --------------
  Aβ40 ^13^C-^13^C     mean C~2~ values   −1.15,−1.60   −1.15,4.35     −1.60,4.35
  t-statistic          0.37               −4.16         −3.98          
  degrees of freedom   15                 12            14             
  p-value              0.72               0.0012        0.0013         
                                                                       
  Aβ40 ^15^N-^13^C     mean C~2~ values   −4.58,−7.47   −4.58, 16.53   −7.47, 16.53
  t-statistic          0.714              −3.38         −3.58          
  degrees of freedom   10                 12            13             
  p-value              0.49               0.0056        0.0032         
                                                                       
  Aβ42 ^13^C-^13^C     mean C~2~ values   −3.07,2.85    3.07,1.80      2.85,1.80
  t-statistic          −1.93              −0.82         0.19           
  degrees of freedom   10                 3             2              
  p-value              0.082              0.47          0.86           
                                                                       
  Aβ42 ^15^N-^13^C     mean C~2~ values   8.32,−8.08    8.32,−7.33     −8.08,−7.33
  t-statistic          1.76               1.06          −0.05          
  degrees of freedom   8                  3             3              
  p-value              0.12               0.37          0.96           

###### Quantification by ELISA of Aβ40/Aβ40 molar ratios in amyloid-enriched brain extracts

Estimated uncertainties are approximately 20%.

  sample   Aβ40/Aβ42 ratio
  -------- -----------------
  t-AD1o   2.4
  t-AD2f   1.4
  t-AD2o   1.0
  t-AD2p   1.5
  t-AD3f   3.4
  t-AD3o   3.8
  t-AD3p   0.7
  PCA1o    0.5
  PCA1p    6.7
  PCA2f    2.2
  PCA2o    4.5
  PCA3f    3.2
  PCA3o    1.8
  PCA3p    2.1
  r-AD1f   3.1
  r-AD1p   4.5
  r-AD2f   4.1
  r-AD2o   1.2
  r-AD2p   1.9
  r-AD3f   0.6
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![Representative TEM images and 2D ssNMR spectra of brain-seeded Aβ40 fibrils\
**a,** Images of negatively-stained fibrils derived from t-AD3f, PCA1o, and r-AD1f tissue, recorded 4 h after initiation of seeded fibril growth (out of 37 fibril samples). Single-headed arrows indicate the periodic modulation of apparent fibril width in a common Aβ40 fibril morphology. Double-headed arrows indicate an additional morphology. **b**, Aliphatic regions of 2D ^13^C-^13^C spectra of the same samples (color coded), with assignments of crosspeak signals to isotopically labeled residues shown in the 2D spectrum of t-AD3f fibrils. Aβ40 was uniformly ^15^N,^13^C-labeled at F19, V24, G25, S26, A30, I31, L34, and M35. Contour levels increase by successive factors of 1.5. 1D slices at 21.0 ppm and 53.5 ppm are shown on the right, with double-headed arrows indicating signals that arise from the less common fibril structures. **c**, 2D ^15^N-^13^C spectra of the same samples, with assignments of the predominant crosspeak signals shown in the 2D spectrum of t-AD3f fibrils and assignments of additional signals shown in the 2D spectrum of r-AD1f fibrils. Contour levels increase by successive factors of 1.3. 1D slices at 112.7 ppm and 121.0 ppm are shown on the right, with double-headed arrows indicating signals that arise from the less common fibril structures.](nihms832197f1){#F1}

![Representative TEM images and 2D ssNMR spectra of brain-seeded Aβ42 fibrils\
**a**, Images of negatively-stained fibrils derived from t-AD3p, PCA1f, and r-AD2p tissue (out of 33 fibril samples). **b**, 2D ^13^C-^13^C spectra of the same samples (color coded), with assignments of crosspeak signals to isotopically labeled residues shown in the 2D spectrum of t-AD3p fibrils. Aβ42 was uniformly ^15^N,^13^C-labeled at F19, G25, A30, I31, L34, and M35. 1D slices at 27.6 ppm and 53.5 ppm are shown on the right. **c**, 2D ^15^N-^13^C spectra of the same samples, with assignments of the crosspeak signals shown in the 2D spectrum of t-AD3p fibrils. Two ^15^N-^13^C~α~ crosspeaks with similar intensities are observed for A30 and I31, indicating similar populations of two distinct fibril structures. 1D slices at 119.5 ppm and 127.1 ppm are shown on the right.](nihms832197f2){#F2}

![Pairwise differences among 2D ssNMR spectra of brain-seeded Aβ40 and Aβ42 fibrils\
RMSD values are displayed on the color scales shown to the right of each plot, with blue shades indicating relatively similar spectra and red shades indicating relatively dissimilar spectra. RMSD plots for Aβ40 fibrils indicate that fibrils derived from t-AD and PCA-AD tissue have similar 2D spectra in most cases, while greater differences are observed in spectra of Aβ40 fibrils derived from r-AD tissue. For Aβ42 fibrils, correlations between RMSD values and tissue categories are not observed. Statistical analyses are summarized in [Extended Data Table 1a](#T2){ref-type="table"}. Shades above white represent significant differences between 2D spectra.](nihms832197f3){#F3}

![Principal component analyses of 2D ssNMR spectra of brain-seeded Aβ40 and Aβ42 fibrils\
For each set of 2D spectra, the coefficients of the first five principal components (C~1~ through C~5~) are plotted in groups corresponding to fibrils derived from different tissue categories. Horizontal bars indicate mean values. The mean value of C~2~ for Aβ40 fibrils from r-AD tissue (n = 8 for 2D ^13^C-^13^C, n = 10 for 2D ^15^N-^13^C) is significantly different from the mean value of C~2~ for Aβ40 fibrils from t-AD (n = 13 for 2D ^13^C-^13^C, n =12 for 2D ^15^N-^13^C) or PCA-AD (n = 9 for 2D ^13^C-^13^C, n = 6 for 2D ^15^N-^13^C) tissue. Statistical analyses are summarized in [Extended Data Table 1b](#T2){ref-type="table"}.](nihms832197f4){#F4}

###### 

Summary of brain tissue samples and 2D ssNMR data.

  patient   gender      age at clinical onset[\*](#TFN1){ref-type="table-fn"}   clinical duration   sample[†](#TFN2){ref-type="table-fn"}   cortical region   Aβ40 ^13^C-^13^C[‡](#TFN3){ref-type="table-fn"}   Aβ40 ^15^N-^13^C   Aβ42 ^13^C-^13^C   Aβ42 ^15^N-^13^C
  --------- ----------- ------------------------------------------------------- ------------------- --------------------------------------- ----------------- ------------------------------------------------- ------------------ ------------------ ------------------
  t-AD1     female      65                                                      11 y                t-AD1f                                  frontal           X                                                 X                  X                  X
  t-AD1o    occipital   X                                                       X                   w                                       n                                                                                                         
  t-AD1p    parietal    X                                                       X                   X                                       X                                                                                                         
  t-AD2     male        64                                                      13 y                t-AD2f                                  frontal           X                                                 X                  X                  X
  t-AD2o    occipital   w                                                       w                   X                                       X                                                                                                         
  t-AD2p    parietal    X                                                       X                   w                                       n                                                                                                         
  t-AD3     male        57                                                      7 y                 t-AD3f                                  frontal           X                                                 X                  X                  X
  t-AD3o    occipital   X                                                       X                   X                                       X                                                                                                         
  t-AD3o′   occipital   X                                                       X                   n                                       n                                                                                                         
  t-AD3p    parietal    X                                                       w                   X                                       X                                                                                                         
  t-AD3p′   parietal    X                                                       X                   n                                       n                                                                                                         
  t-AD4     female      51                                                      11 y                t-AD4f                                  frontal           X                                                 X                  w                  n
  t-AD5     female      65                                                      5 y                 t-AD5f                                  frontal           X                                                 X                  w                  n
  t-AD6     female      58                                                      21 y                t-AD6f                                  frontal           X                                                 X                  w                  w
  PCA-AD1   male        55                                                      9 y                 PCA1f                                   frontal           X                                                 w                  X                  X
  PCA1o     occipital   X                                                       X                   X                                       n                                                                                                         
  PCA1p     parietal    X                                                       n                   X                                       X                                                                                                         
  PCA-AD2   male        56                                                      6 y                 PCA2f                                   frontal           X                                                 X                  X                  X
  PCA2o     occipital   X                                                       X                   X                                       w                                                                                                         
  PCA2p     parietal    X                                                       X                   w                                       n                                                                                                         
  PCA-AD3   male        58                                                      10 y                PCA3f                                   frontal           X                                                 X                  X                  w
  PCA3o     occipital   X                                                       w                   X                                       X                                                                                                         
  PCA3p     parietal    X                                                       X                   w                                       w                                                                                                         
  r-AD1     male        79                                                      3 m                 r-AD1f                                  frontal           X                                                 X                  w                  w
  r-AD1p    parietal    X                                                       X                   w                                       n                                                                                                         
  r-AD2     male        83                                                      6 m                 r-AD2f                                  frontal           w                                                 X                  X                  X
  r-AD2f′   frontal     X                                                       X                   n                                       n                                                                                                         
  r-AD2o    occipital   X                                                       X                   n                                       n                                                                                                         
  r-AD2p    parietal    X                                                       X                   X                                       X                                                                                                         
  r-AD2p′   parietal    X                                                       X                   n                                       n                                                                                                         
  r-AD3     female      73                                                      8 m                 r-AD3f                                  frontal           w                                                 X                  X                  X
  r-AD4     female      74                                                      18 m                r-AD4f                                  frontal           X                                                 X                  w                  n
  r-AD5     female      66                                                      21 m                r-AD5f                                  frontal           X                                                 X                  w                  n
  r-AD6     female      65                                                      18 m                r-AD6f                                  frontal           w                                                 n                  n                  n
  ND1       female      73                                                      \--                 ND1f                                    frontal           X                                                 X                  w                  X
  ND2       male        88                                                      \--                 ND2f                                    frontal           X                                                 w                  w                  n
  ND3       male        83                                                      \--                 ND3f                                    frontal           w                                                 w                  n                  n

For ND samples, age at death.

Samples t-AD3o′, t-AD3p′, r-AD2f′, and r-AD2p′ are separate cortical tissue samples from the same patients and brain regions as t-AD3o, t-AD3p, r-AD2f, and r-AD2p, respectively.

X = data obtained; w = data obtained, but low signal-to-noise; n = data not obtained
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